To the Editor: Diversity of genotypes among Pneumocystis jirovecii (human-specifi c Pneumocystis species) isolates mainly involves internal transcribed spacer (ITS) loci (1) . Type Eg, one of the most frequently detected ITS genotypes, has been found worldwide (2) . The locus of dihydropteroate synthase (DHPS) is also of interest because DHPS is the target of sulfonamides, the main drugs used to treat Pneumocystis pneumonia (PCP). Studies of the DHPS locus have found mutations at positions 165 and 171, which confer potentially lower sensitivity to sulfonamides to mutant P. jirovecii organisms (3) .
Airborne transmission of Pneumocystis ssp. has been demonstrated among animals and probably occurs among humans (4) . Reports of clusters of PCP cases in hospitals (4,5) provide a rationale for considering the possibility of nosocomial P. jirovecii infections.
Moreover, we recently quantifi ed P. jirovecii in the air surrounding patients with PCP (6). Our fi ndings suggested that the fungus is exhaled from infected patients and then spreads into their surrounding air.
Because matches of P. jirovecii genotypes between pulmonary and air samples would strengthen these fi ndings, we conducted DHPS and ITS typing of P. jirovecii isolates from PCP patients and from the air in their close environment. We assayed P. jirovecii DNA that we had previously detected in pulmonary samples (bronchoalveolar lavage and induced sputum) from 15 PCP patients and in 15 air samples collected 1 meter from each patient's head (6) .
ITS genotyping was based on sequence analysis of ITS 1 and 2 regions after amplifi cation with a nested PCR, cloning, and sequencing, as described (7) . ITS alleles were identifi ed by using the typing system by Lee et al. (2) . DHPS genotyping was based on a PCR restriction fragment-length polymorphism assay that enables detection of mutations at positions 165 and 171, as described (8) .
Among the 15 pulmonary samples, ITS genotyping was successful for all 15; among these, 8 ITS genotypes were identifi ed (Table) . Type Eg was most frequently identifi ed. Mixed infections, which correspond to detection of >1 genotype in a given sample, were detected in 5 samples. DHPS genotyping was successful for all 15 pulmonary samples. A wild genotype was identifi ed in 9 samples, a 165 mutant genotype in 1 sample, and a 171 mutant genotype in 2 samples. Mixed infections were identifi ed in the 3 remaining samples.
Among the 15 room air samples, ITS genotyping was successful for 7; among these, 4 ITS genotypes were identifi ed (Table) was identifi ed in 1 sample. These results enabled us to compare DHPS genotypes for 6 pairs of samples. A full match was found for these 6 pairs. DHPS and ITS genotype matches were found for 4 pairs. Several lines of evidence suggest that P. jirovecii is exhaled by infected patients and transmitted by the airborne route to susceptible persons (4). In the study reported here, ITS or DHPS genotype matches between pairs of pulmonary and air samples are consistent with the possibility that P. jirovecii organisms in the air originated from patients. DHPS mutants were detected in 6 (40%) of the 15 pulmonary samples; none of the15 patients had received sulfonamide treatment at the time of PCP diagnosis. These results were not unexpected because frequency of fi nding DHPS mutants in PCP patients in Paris who had no prior sulfonamide treatment is high (8) . The exhalation of DHPS mutants from infected patients can spread potentially sulfonamideresistant organisms.
Matches of P. jirovecii genotypes in pairs of pulmonary and room air samples argue in favor of P. jirovecii exhalation by infected patients. The exhalation of P. jirovecii organisms emphasizes the risk for their nosocomial transmission. Our data provide additional arguments in favor of the application of measures to prevent the airborne transmission of P. jirovecii in hospitals. 
Fatal Human
Co-infection with Leptospira spp. and Dengue Virus, Puerto Rico, 2010
To the Editor: Leptospirosis, caused by Leptospira spp. bacteria, and dengue, caused by dengue viruses (DENVs), are potentially fatal acute febrile illnesses (AFI) endemic to the tropics (1,2). Because their clinical manifestations are similar (3), leptospirosis may be misidentifi ed as dengue (4) . We report a fatal case of co-infection with Leptospira spp. and DENV-1 in a man in Puerto Rico.
On May 23, 2010, a 42-year-old unemployed male carpenter came to an outpatient clinic in Puerto Rico reporting a 4-day history of fever, headache, generalized myalgia, anorexia, nausea, and vomiting. He was being treated for chronic hypertension and had been released from jail 2 weeks before illness onset. On evaluation, he was febrile, hypertensive, and tachycardic; laboratory results showed thrombocytopenia and leukocytosis with a predominance of neutrophils. Viral syndrome was diagnosed, and the patient was given acetaminophen, solumedrol, and ketoprofen.
The patient returned to the clinic on May 25 with continued fever, myalgia, worsening headache, and bilateral calf pain; he was afebrile and tachycardic and appeared acutely ill. He had no rash, jaundice, icteric sclera, cardiac murmurs, or organomegaly, and his
